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THE thermolabile character of chicken sarcoma I filtrates has been noted since
1919 (Rous, Robertson and Oliver, 1919). Later, it was found that incubation
at 37' C. for 24 hours resulted in a rapid loss of infectivity even in filtrates of
high titre and that inactivation was invariably complete after treatment at
55' C. for 15 minutes. Mueller (1928) first mentioned Gye's finding that this
inactivation of Rous I filtrates at moderate temperatures could be prevented for
periods up to three days by the addition of HCN.
Gye (1925) ascribed this phenomenon of inactivation to the oxidation of a
specific factor ", but later inclined to the view that inactivation'was due to
proteolytic ferments in the filtrates acting on a non-living protein specific
factor
" (Gye and Purdy, 1930). In the light of Oppenheimer's finding that
substances like HCNalthoughpowerful anti-oxidants, had little effect onproteases
(Oppenheimer, 1925), Mueller (1928) adhered to Gye's earliertheory that inactiva-
tion was a result of oxidation of a specific component of the virus.
Pirie and Holmes (1931) argued that since incubation at 370 C. even under
anaerobic conditions resulted in a loss ofpotency of Rous I filtrates, atmospheric
oxygen needplay no part in any oxidation which is assumed to accompany Rous I
virus inactivation. They suggested therefore that some oxidiser-catalyst system
was closely attached to the virus itself, while admitting that it had not been
possible to separate it from the virus nor to identify it chemicany.
With theexception ofRous I there is no information on the effect ofincubation
on the avian tumour viruseg. It was thought that a comparative study on the
effect of incubation at 370 C. for varying periods of time on the "infectivity
" of
partially purified Rous 1, MH2 (Murray and Begg, 1930), and PRC4 (Carr and
Campbell, 1958) virus preparations might be ofinterest, if an attempt were made
to correlate any effect on potency with virus material liberated and detected by
u.v. spectrophotometric analysis.
MATERIALS AND METHODS
Preparationofnormal cellparticulate su8pensions andofvirus suspensions
Suspensions of cell particulates from normal fowl tissues (liver and spleen),
from a non-filterable fowl sarcoma, GRCH 16 (Peacock and Peacock, 1953) and
partially purified virus suspensions from Rous 1, MH2 and PRC4 tumours, were
preparedby the methodoriginally devisedby Carr and Harris (1951) and modified
by Bather (1953). In each series ofexperiments the same initial weight of tissue
was used as starting material for the preparation of each of the five suspensions.INCUBATION OF FOWL TUMOUR VIRUSES 307
Bioassay
Chickens from the highly susceptible inbred Brown Leghorn line maintained
at the Poultry Research Centre were used for the bioassay of the three virus
preparations before and after treatment.
These birds have been selected for susceptibility to Rous I sarcoma cells and
virus, and allow infectivity titrations to be made in young chickg to a constant
end-point (Carr and Harris, 1951). The method of Parker and Rivers (1936) was
used to estimate the second figure in the end-point dilution. Groups of 4 chicks
were used for each serial ten-fold dilution of virus.
The initial untreated virus preparation was made in each casebyresuspending
the
" pellet
" obtained after the final high-speed centrifugation in as many ml. of
Mcllvaine'sphosphate-citric buffer(pH 7-2) as there weregrams of
" wet tumour ",
so that the concentration of virus before titration was such that I ml. = I mg.
tumour.
" Infectivity
" was always recorded as m.i.d./g. of tumour (Carr and
Harris, 1951).
EXPERIMENTS
In each experimental series the
"infectivity
" of the three partially purified
virus suspensions was estimated by the bioassay method outlined above. The
non-infective character of the GRCH and
" normal
" cell particulate suspensions
was confirmed by inoculation of the undiluted preparations into 4 chicks.
Equal volumes of each of the 5 suspensions suitably diluted (10-1) were sub-
jected to the following treatments:
(1) Heated to 100' for 15 minutes.
(2) Incubated at 37' C. for 4 hours.
(3) 370 C. 8
(4) 370 C. 16
(5) 370 C. 24
(6) 370 C. 24 with addition ofm/1 KCN.
(7) Maintained at 00 C. for 24 hours.
In each case after treatment, thevirus/ceRparticulate was sedimentedbyhigh
speed centrifugation-15,000 g. for 55 minutes-and the supernatantpipetted off,
diluted appropriately and examined in the u.v. spectropbotometer (Unicam SP
500) at wave-lengths between 2400 A and 3000 A. Optical density was plotted
against wave-length and the curves compared. The residue from each treatment,
in the case ofthe three viruses, was resuspended in Mcllvaine's bufferpH 7-2 and
tested for potency.
Aseptic technique was observed throughout; tests for the presence of con-
taminating bacteria using nutrient agar slopes incubated at 370 C., were negative.
The results of niany series ofexperiments including some or all of the 7 treat-
ments described above, were consistent ; to avoid repetition only those for the
most detailed series are reported.
RESULTS
Infectivity
During the first four hours of incubation at 370 C. there is an appreciable
decrease in infectivity of each of the three fowl tumour viruses, Rous 1, MH2and
PRC4. This loss of potency continues with further incubation until by the endr..
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of 24 hours the virus preparations are completely non-infective. Boiling for 15
minutes also results in a complete loss ofactivity of the three virus preparations.
Most of the infectivity of the three virus preparations is retained for 24 hours
after incubation at 37' C. with the addition of KCN or after storage at O' C.
(Tables 1, II and III). Table IV summarises the 24 hour data alone from other
experiments.
TABLE I.-Effect of Experimental Treatments on Infectivity of Partially Purified
Rous I Viru8 Preparations
Dilution ofsample
and number of tumours
from 4 inoculations
of each dilution
10-1 10-2 10-3 10-4 lo-5
4/4 4/4 1/4 0/4 0/4
4/4 1/4 0/4
1/4 0/4 0/4
1/4 0/4 0/4
0/4 0/4 0/4
4/4 3/4 0/4
0/4 0/4 0/4
4/4 3/4 0/4
" Infectivity
"
ofsample
(m.i.d./g.
tumour)
102.7
101.7
100.7
100.7
0
102.3
0
102.3
Treatment
Initially untreated .
37' C. for 4 hours
37' C. for 8 hours
37' C. for 16 hours
37' C. for 24 hours
37' C. for 24 hours (+ KCN) .
100' C. for 15 minutes .
O' C. for 24 hours
TABLE II.-Effect of Experimental Treatment,8 on Infectivity of Partially Purified
MH2 Viru8 Preparation
" Infectivity
"
ofsample
(m.i.d./g.
tumour)
lo4.7
103.3
103.0
101.7
0
104.5
104.7
I
10-15
1/4
0/4
0/4
0/4
0/4
1/4
Treatment
InitiaRy untreated .
37' C. for 4 hours
37' C. for 8 hours
37' C. for 16 hours
37' C. for 24 hours
37' C. for 24 hours (+ KCN) .
100' C. for 15 minutes .
O' C. for 24 hours
10-2 10-3
4/4 4/4
4/4 3/4
4/4 2/4
1/4 0/4
4/4 4/4
4/4 4/4
10-19
4/4
0/4
0/4
0/4
4/4
4/4
TABLE III.-Effect ofExperimental Treatments on Infectivity ofPartially Purified
PRC4 Viru-3 Preparation
Dilution ofsample
and number of tumours
from 4 inoculations
of each dilution
'k
10-2 10-3 1O-fi
4/4 4/4 3/4
4/4 2/4 0/4
0/4 0/4 0/4
0/4 0/4 0/4
0/4
4/4 4/4 1/4
4/4 4/4 3/4
" Infectivity
"
ofsample
(m.i.d./g.
tumour)
104.3
103.0
101.6
101.0
0
103.7
0
104.3
Treatment
InitiaRy untreated .
370 C. for 4 hours
37' C. for 8 hours
370 C. for 16 hours
370 C. for 24 hours
370 C. for 24 hours (+ KCN) .
100' C. for 15 minutes .
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TABLE IV.-Effect on
" Infectivity
" of Tumour Viru8 Su8pen8ion8 and Contro18
Incubated at 37' C. for 24 hour8, Compared with Optical Den8ity at 2800 A of
Material Liberated in Four Serie8 ofExperiment8
Normal
cell
Experi- Rous I particu-
i-nent Rous I MH2 PRC4 (+ KCN) lates GRCH
I Decrease in infectivity 2- 7 4- 7 4-3 0-4
(log units)
Optical density 0-16 0-26 0
- 20 0 02 0-1 0 08
at 2800 A
2 Decrease in infectivity 5
- 3 3 7 2
- 5 0-6
(log units)
Optical density 0 35 0-18 0-13 O- 04 0 05 O- 03
at 2800 A
3 Decrease in infectivitv 4- 3 3
- 5 4- 0 0- 6
(log units)
Optical density 0
- 28 0-13 0 22 0 02 0 08 O- 05
at 2800 A
4 Decrease in infectivity 3 0 5 5 3 7 0- 3
(log units)
Optical densitv 0-15 O- 34 0
- 2 0.04 0-1 0 05
at 2800 A
If we assume an initial infectivity of I00 per cent for the untreated virus
preparations, which always fell to zero after 24 hours' incubation at 37' C., then
the percentage infectivity at 4, 8 and 16 hours can be estimated from the biossay
results, and survival curves deduced. On the basis of such curves it is possible to
compare the rates of death of Rous 1, MH2 and PRC4 viruses under the conditions
of these experiments. In this way we obtain a half-life for Rous I virus of
approximately 324 niinutes (coinpared with 155 minutes found by Rubin in his
experiments (Rubin, 1955)) for MH2 of 12 hours and 6-3 hours for PRC4 (Fig. 3).
Ultra-violet ab8orption
The significant section of the u.v. spectrum examined from 2400-3000 A is
that represented in Fig. I and 2, i.e. between 2650 A and 2900 A. Each of the
three virus preparations incubated at 37' C. yields material which absorbs strongly
in the region 2750-2800 A, and is very likely protein. The amount of protein-
like material released increases as the time ofincubation proceeds from 4-24 hours
(Fig. 2). GRCH 16 preparations and suspensions of normal cell particulates
incubated at 37' C. for precisely the same periods as the virus suspensions, do not
release material with any detectable u.v. absorption peak in the range examined
(Fig. 1).
If the amount of proteiD-like material (as estimated by spectral absorption
maxima) released by each of the three viruses is plotted over the time range
4-24 hours, the curves parallel those showing percentage decrease of infectivity
with time (Fig. 3).
KCN successfully inhibits the shedding of protein-like material from all three
virus preparations inciibated at 37' C. for 24 hours (Fig. 1).310 H. A. DRAYTON
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Fic- I.-Ultra-violet absorption spectra of supernatants derived from preparations indicated
after incubation at 37' C. for 24 hours.
2650 2700 2750 2800
WAVELENGTH
2850 2900
FIG. 2.-Ultra-violet absorption spectra of supernatants derived from PRC4 virus preparation
after incubation at 37' C. for the times indicated.311 INCUBATION OF FOWL TUMOUR VIRUSES
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Fia. 3.-Survival curves for PRC4 virus incubated at 37' C. for periods up to 24 hours.
(A) From infectivity results.
(B) From absorption spectral maxima.
DISCUSSION
The results of these experiments indicate that the decrease in infectivity of
partially purified Rous 1, MH2 and PRC4 virus preparations incubated at 37' C.
for a period of 4-24 hours is accompanied by the liberation ofincreasing amounts
of protein-like material in the supernatants after sedimentation. Normal cell
particulate and non-virus tumour-GRCH 16-preparations treated in the same
manner do not yield material with any detectable absorption peak in the range
examined. We can conclude therefore that the protein-like material released in
these experiments was derived from the virus particles and not from the host cell
contaminants present in some degree in all fowl tumour virus preparations.
This gives confirmation to the theory that the inactivation which ensues after
incubation of Rous 1, as with MH2 and PRC4 virus preparations incubated at
37' C. for periods up to 24 hours results from actual decomposition of virus
protein and not merely by simple oxidation which would alter the molecular
configuration but would in no way affect its integrity. It is unlikely, however,
in view of the u.v. absorption spectra of the material liberated that proteases are
implicated in the breakdown as suggested by Gye (Gye and Purdy, 1930).
The decomposition of virus protein is known to be reduced by traces of
biological materials (Adams, 1948) and quite possibly from the protein-like
material liberated in these experiments. It is therefore very sensitive to in-
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significant changes in experimental procedure (e.g. total volume of fluid) and the
rates of decomposition may then vary from those reported.
The absence of detectable nucleic acid in the supernatants after any of the
treatments would suggest that the protein-like material liberated during inactiva-
tion, is not that which is bound to ribonucleic acid in the nucleoids of Rous I
virus particles (Epstein, 1958), but is derived from some part of the external coat.
SUMMARY
1. Experiments are described in which the effect ofincubation on the biological
activity of Rous I, MH2 and PRC4 purified virus preparations, as determined by
bioassay methods, is studied in relation to virus constituents liberated, as de-
termined by u.v. spectrophotometry.
2. Infectivity of Rous I, MH2 and PRC4 virus preparations decreased to zero
after incubation at 370 C. for 24 hours and after boiling for 15 minutes.
3. The decrease in infectivity of the three virus preparations incubated at
370 C. for various periods up to 24 hours was paralleled by the liberation of
increasing amounts of material, which absorbs strongly in the u.y. at 2750-2800 A
and is very likely protein. Since no such material was detected in GRCH 16 and
normal cell particulate controls, it is concluded that the protein-like material was
derived from the virus particles.
4. The loss of infectivity which ensues on incubation of Rous I, MH2 and PRC4
virus preparations is associated not merely with simple oxidation but by actual
decomposition of constituent virus protein.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign.
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